Gilles Alberici, PharmD, PhD
Gilles has 30 years of experience in the pharmaceutical and biotechnology sectors. He created and developed OPi, Pharmaceuticals for Rare Diseases and has taken more than ten products through clinical trials. Gilles is the President and Founder of initiative OCTALFA, an organization dedicated to the inception and management of drug development companies. He was elected Executive Chairman of ORPHELIA Pharma in 2015.